CONCENTRATIONS |
6 Months Ended |
|---|---|
Jun. 30, 2025 | |
| CONCENTRATIONS | |
| CONCENTRATIONS | (13) CONCENTRATIONS For the three months ended June 30, 2025, the Company sourced approximately 67% of the supplies for its electrotherapy products from four significant vendors. For the same period in 2024, the Company sourced approximately 49% of the supplies for its electrotherapy products from three significant vendors. Significant vendors provided at least 10% of the total value spent on the Company’s electrotherapy products during the period. For the six months ended June 30, 2025, the Company sourced approximately 45% of supplies for its electrotherapy products from three significant vendors. For the same period in 2024, the Company sourced approximately 40% of supplies for its electrotherapy products from three significant vendors. At June 30, 2025 and December 31, 2024, the Company had no gross receivables from any third-party payers that made up over 10% of the net accounts receivable balance. |